Clinical Trial: Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: PROCAS: Study Observational Prospective and Multicenter to Determine the Clinic Effectiveness and the Safety of Caspofungin Acetate (CANCIDAS®) in the Treatment of Invader Fungal Infection

Brief Summary: We wanted to determine the efficacy and the safety of caspofungin acetate (CANCIDAS®) in the treatment of invader fungal infection (IFI) specifically, Invasive Candidiasis (CI) in adults patients without neutropenia and Invasive Aspergillosis (AI) in adults patients who are refractory to or intolerant of other therapies (i.e., amphotericin B, lipid formulations of amphotericin B, and/or itraconazole).

Detailed Summary: Study post-marketing (observational). It is multicenter and prospective. No masking is used, without control group neither is randomized
Sponsor: PETHEMA Foundation

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: PETHEMA Foundation

Dates:
Date Received: October 13, 2006
Date Started: March 2004
Date Completion:
Last Updated: May 11, 2009
Last Verified: May 2009